Patents by Inventor Kirk Conrad

Kirk Conrad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of relaxin to treat nephrogenic diseases of water imbalance involving aquaporin-4
    Patent number: 9119833
    Abstract: The present disclosure relates to methods of modulating aquaporin channels. Particularly, the disclosure provides methods of modulating aquaporin channels in a tissue of a mammal by administering relaxin.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: September 1, 2015
    Assignees: University of Melbourne, University of Florida Research Foundation, Inc.
    Inventors: Laura Parry, Kirk Conrad
  • Modulating Aquaporins with Relaxin
    Publication number: 20140066377
    Abstract: The present disclosure relates to methods of modulating aquaporin channels. Particularly, the disclosure provides methods of modulating aquaporin channels in a tissue of a mammal by administering relaxin.
    Type: Application
    Filed: November 8, 2013
    Publication date: March 6, 2014
    Inventors: Laura Parry, Kirk Conrad
  • MODULATING AQUAPORINS WITH RELAXIN
    Publication number: 20130053318
    Abstract: The present disclosure relates to methods of modulating aquaporin channels. Particularly, the disclosure provides methods of modulating aquaporin channels in a tissue of a mammal by administering relaxin.
    Type: Application
    Filed: March 10, 2011
    Publication date: February 28, 2013
    Inventors: Parry Laura, Kirk Conrad
  • Use of relaxin to increase arterial compliance
    Publication number: 20050238639
    Abstract: The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present invention further provides methods of increasing arterial compliance in individuals who have Type 1 or Type 2 diabetes. The present invention further provides methods of increasing arterial compliance in perimenopausal, menopausal, and post-menopausal women. The present invention further provides methods of increasing arterial compliance in individuals who have or who are at risk of developing age-associated arterial stiffness.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 27, 2005
    Applicant: BAS Medical, Inc.
    Inventors: Kirk Conrad, Sanjeev Shroff